
Albireo Pharma ALBO
Quarterly report 2022-Q3
added 11-08-2022
Albireo Pharma Depreciation & Amortization 2011-2026 | ALBO
Annual Depreciation & Amortization Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 274 K | 192 K | 127 K | 45 K | 35 K | 14 K | 15 K | 603 K | 641 K | 725 K | 938 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 938 K | 14 K | 328 K |
Quarterly Depreciation & Amortization Albireo Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 322 K | 198 K | 114 K | - | 167 K | 75 K | 37 K | - | 119 K | 77 K | 39 K | - | 89 K | 50 K | 11 K | - | 33 K | 22 K | 53 K | - | 23 K | 13 K | 5 K | - | 11 K | 7 K | 4 K | 30 K | 211 K | 164 K | - | 102 K | 462 K | 310 K | 102 K | 156 K | 484 K | 326 K | 156 K | 167 K | 555 K | 382 K | 167 K | 194 K | 732 K | 502 K | 194 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 732 K | 4 K | 172 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
1.13 M | $ 1.06 | -4.5 % | $ 5.78 M | ||
|
Aclaris Therapeutics
ACRS
|
807 K | $ 3.01 | 3.79 % | $ 233 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | ||
|
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.99 | 1.02 % | $ 508 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
BioVie
BIVI
|
229 K | $ 1.16 | 2.65 % | $ 1.71 M | ||
|
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | ||
|
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 0.2 | 8.46 % | $ 435 M | ||
|
Catalyst Biosciences
CBIO
|
1.07 M | $ 11.86 | 2.24 % | $ 781 M | ||
|
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | ||
|
Certara
CERT
|
1.99 M | $ 8.81 | -0.56 % | $ 1.41 B | ||
|
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | ||
|
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | ||
|
Celldex Therapeutics
CLDX
|
3.18 M | $ 27.16 | 2.76 % | $ 1.75 M | ||
|
Cellectar Biosciences
CLRB
|
192 K | $ 2.95 | 7.66 % | $ 36.1 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.2 M | $ 26.78 | -0.81 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
6.43 M | $ 9.61 | 0.63 % | $ 141 M | ||
|
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | ||
|
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | ||
|
CorMedix
CRMD
|
70.8 K | $ 11.63 | -6.81 % | $ 592 M | ||
|
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
48.4 M | $ 567.93 | -0.73 % | $ 43 B | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
5.38 M | $ 2.6 | 1.96 % | $ 16.3 M | ||
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M |